Clinical Trial Update: A Trial Comparing Combination Treatment (Solifenacin Plus Mirabegron) With One Treatment Alone (Solifenacin) [Phase 3]

View source ↗

Summary

This Phase 3 trial assessed whether adding mirabegron to solifenacin improves outcomes for overactive bladder compared with solifenacin alone. The study has com…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Overactive Bladder

Drugs mentioned

• Mirabegron (mirabegron)
• Solifenacin (solifenacin)

Snippet

Sponsor: Astellas Pharma Europe Ltd. | Conditions: Urinary Bladder Diseases, Urinary Bladder Overactive | Phase 3 | Status: COMPLETED | Results posted: 2017-10-09